Navigation Links
Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team
Date:11/21/2011

NOVATO, Calif., Nov. 21, 2011 /PRNewswire/ -- Ultragenyx Pharmaceutical, Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that Tom Kassberg has joined the company as Chief Business Officer. Mr. Kassberg will be responsible for leading the company's business development and corporate strategic planning activities, as well as the human resources and legal affairs functions. Mr. Kassberg brings to Ultragenyx more than twenty years of experience in the pharmaceutical and biotechnology industries.

Before joining Ultragenyx, Mr. Kassberg consulted with Corium International, Inc. and Rib-X Pharmaceuticals, Inc., and previously served as Executive Vice President of Corporate Development at Proteolix, Inc.  He has also held management positions at InterMune, Inc., Plexxikon, Inc. (a company he co-founded), and SUGEN, Inc.  Mr. Kassberg started his career at Bristol-Myers Squibb where he held a variety of positions in finance, product and market analysis, and sales. Mr. Kassberg received his M.B.A. from the Kellogg Graduate School of Management at Northwestern University and his B.A. from Gustavus Adolphus College in Minnesota.

"Tom joins Ultragenyx at an exciting time in our company's growth, as our clinical pipeline is advancing and expanding, and our talented management team is in place," said Emil D. Kakkis, M.D., Ph.D., Chief Executive Officer of Ultragenyx. "Tom brings to Ultragenyx a wealth of industry and operational experience and a successful track record of value-creating transactions that will help Ultragenyx become a successful biopharmaceutical business."

The appointment of Mr. Kassberg complements the Ultragenyx management team, which is comprised of rare disease development experts with broad experience in early-stage as well as established pharmaceutical companies. The management team includes the following key management personnel:


    SOURCE Ultragenyx Pharmaceutical, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Ultragenyx Granted Orphan Drug Designation for UX001 SA-ER for the Treatment of Hereditary Inclusion Body Myopathy (HIBM)
    2. Ultragenyx Initiates Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Muscle Wasting Disease
    3. CVS Caremark Appoints Kevin Murphy President of Accordant Business
    4. Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer
    5. Adeona Appoints Jeff Lucero Riley as Independent Chairman
    6. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
    7. InterMune Appoints Angus C. Russell to Board of Directors
    8. Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
    9. Vanda Pharmaceuticals Appoints Chief Commercial Officer
    10. Cardica Appoints Christopher Littel VP, Sales and Marketing
    11. S1 Pharmaceuticals Appoints Robert Taylor Segraves, MD, PhD, and Robert Pyke, MD, PhD to Its Scientific Advisory Board
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... 31, 2015  Xcelience, a contract development and ... made a structured cash investment in Powdersize, a ... milling, micronization and powder size classification within the ... business while simultaneously adding a complete set of ... capabilities. "As we continue to ...
    (Date:7/31/2015)... SAN DIEGO , July 31, 2015 ... Eisai Co., Ltd. (Headquarters: Tokyo , ... Halozyme Therapeutics, Inc. (Headquarters: San Diego, California ... , "NASDAQ: HALO") have signed a clinical collaboration agreement ... , "eribulin") in combination with Halozyme,s investigational drug PEGPH20 ...
    (Date:7/30/2015)... 2015 Edwards Lifesciences Corporation (NYSE: EW ), ... hemodynamic monitoring, today announced that Robert A. Ingram ... "Bob is an ardent champion for innovation in the lifesciences ... him on Edwards, board as we pursue our focused innovation ... CEO.  "Bob has provided a valuable perspective to our board, ...
    Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6
    ... presented an interim study analysis indicating that MENOPUR® (menotropins ... fertilization (IVF) cycles using a gonadotropin-releasing hormone (GnRH) ... the 65th Annual Meeting of the American Society for ... , MENOPUR® vs. rFSH in GnRH Antagonist ...
    ... China, Oct. 20 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,(NYSE: ... leading pharmaceutical company,specializing in development, manufacturing, and marketing ... announced an agreement with,OSI Pharmaceuticals, Inc., to develop, ... , Headquartered in Long ...
    Cached Medicine Technology:Research Compares MENOPUR(R) With rFSH in GnRH Antagonist IVF Cycles 2Research Compares MENOPUR(R) With rFSH in GnRH Antagonist IVF Cycles 3Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 2Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 3
    (Date:8/1/2015)... ... August 01, 2015 , ... Calvary Hospital today announced that it is ... campus. The goal is to bring this Torah – dating from 1880 – back ... and religious services. , Scroll No. 515, from the town of Taus-Domazlice, is ...
    (Date:8/1/2015)... ... 2015 , ... On Tuesday, July 28th, Symantec released a security industry ... behind the attack on Anthem Inc. which resulted in one of the largest data ... and spear phishing campaigns. , For Joe Caruso, founder and CEO/CTO of ...
    (Date:8/1/2015)... ... 2015 , ... On March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community ... by stepping off Springer Mountain and heading north. Since that day, Phil has hiked ... and was greeted by friends and family. He visited CCAR and left an inspirational ...
    (Date:7/31/2015)... ... 01, 2015 , ... The Honor Society of Nursing, Sigma Theta Tau International ... Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. Key nurse leaders from ... Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit of Human Resources for ...
    (Date:7/31/2015)... ... July 31, 2015 , ... Recently touted by Becker’s Healthcare ... health analytics , Jvion continues to disrupt the predictive analytic and big data ... patient and population level illness to drive prevention and better health outcomes. Most ...
    Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2
    ... WATERTOWN, Mass. , Jan. 12 Research shows ... also good for the brain, according to the Alzheimer,s Association. ... temperatures to get in shape for the Boston Marathon(R) on ... to keep in shape as well. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20100112/DC36305LOGO ...
    ... heart disease, experts say , TUESDAY, Jan. 12 (HealthDay News) ... the thighs and buttocks may be better for you than ... of the data on the subject suggests it may even ... of lower body, that is, gluteofemoral fat that is striking," ...
    ... , , COLTS NECK, N.J. , Jan. ... a bold resolution for 2010 and it,s kicking off in ... it will open a 14,200 square-foot club in Smyrna ... locations to open within 24 months. Retrofitness already has 54 locations ...
    ... , , SHENZHEN, China , ... www.htdsmedical.com ) announced that its directors have resolved that up ... sale of its MindUp division to Hiru will be distributed to ... Terry Yuan , HTDS President, said, "In our efforts to maximize ...
    ... risk of developing the most common form of renal cell cancer, ... journal BJUI . US researchers found that obese patients ... a clear-cell renal cell cancer (RCC) than patients with a body ... by four per cent for every extra BMI point. The ...
    ... The American College of Physicians (ACP) has issued ... patients, physicians, and caregivers. The Journal ... Caregivers, Patients and Physicians: Ethical Guidance to Optimize ... resources to help physicians manage relationships with patients ...
    Cached Medicine News:Health News:The Run for the Memory Marathon Team Getting in Shape and Fighting Alzheimer's 2Health News:The Run for the Memory Marathon Team Getting in Shape and Fighting Alzheimer's 3Health News:The Run for the Memory Marathon Team Getting in Shape and Fighting Alzheimer's 4Health News:Could a Bigger Bottom Boost Health? 2Health News:Could a Bigger Bottom Boost Health? 3Health News:Hot Fitness Concept Comes to Atlanta 2Health News:Hard To Treat Diseases (HTDS) To Disperse Special One Time Hiru (HIRU) Common Stock 2Health News:Hard To Treat Diseases (HTDS) To Disperse Special One Time Hiru (HIRU) Common Stock 3Health News:Hard To Treat Diseases (HTDS) To Disperse Special One Time Hiru (HIRU) Common Stock 4Health News:Obesity linked to common form of kidney cancer and each extra BMI point increases risk 2Health News:New ethical guidance from ACP for patient-physician-caregiver relationship 2
    Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm....
    Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Mini-type 1/1 (mm), opening width 4.0 mm and length 8.2 mm....
    Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm....
    Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
    Medicine Products: